Professional Documents
Culture Documents
Colton Coey
English 1201
24 October 2021
“Cancer is the second leading cause of death in the United States” (Centers for Disease
Control). With so many loved ones being taken away from families, one would think that cancer
patients receive proper medical care. However, in the United States where citizens must pay for
healthcare, this is not the case. This is coming from first-hand experience of a family member not
being able to afford Chemo. Primitive U.S laws are the deciding factor of whether someone will
choose to go to a screening or choose to pay rent. The people who passed the bill for healthcare
would have expected something to change by now but the U.S is stuck in its old ways. The rest
of the world has adopted universal healthcare but when will the U.S? Paying for
healthcare causes cancer patients to refuse and delay treatment because of the cost, leading to a
Figure 1 a study by the Centers for Disease Control shows the rate of new cases in the top 10
Healthcare costs are unreasonably high and rising. Getting prescriptions filled and just
having cancer increases the cost of healthcare. According to BlueCross, BlueShield, “Growth in
U.S Prescription Drug Spending… The High Cost of Treating Chronic Diseases… How We Live
Affects Healthcare Costs” (BlueCross, BlueShield). An uninsured patient will be paying for each
oral treatment and be paying more because they are a higher risk for insurance companies. If the
patients have mental health issues and find out they have cancer, the burden of the high cost in
addition to the problems they might already have such as depression may cause many patients to
make adverse decisions when it comes to medical care. Not only might they avoid care but if
patients choose to go to the hospital then they will be paying for the additional days they are in
Coey 3
the hospital. According to an article by Lin Bai, “Cancer patients with depression would accrue
higher direct medical costs and medication costs, and pay more out-of-pocket for healthcare than
those without depression” (Bai et al.). Patients must pay based on the level of risk the insurance
company decides on. This includes if the patient has a complex cancer that would be hard to treat
making them an “end of life” patient. According to an article by Brett Doble, “Healthcare costs
for patients with cancer are most expensive immediately after diagnosis and close to death”
(Doble et al. 35). Patients with complex cancers will be labeled as high risk or “close to death”
by companies and will have to pay more, which may make them deny care.
Cancer patients, (will be referred to as just patients) are more likely to avoid screenings
the more expensive the procedure is. The likely hood of patients skipping out on screenings
exponentially increases as the cost increases by the hundreds. According to an article by Crissy
Flake, “the rate of those delaying or deferred necessary medical care in the United States rose
from 1 in 7 to 1 in 5” (Flake & Robert). Screenings are not just important to see if someone has
cancer, but they are even more important to see if someone whose already been diagnosed has
recurring cancer. This is important because about double the number of patients diagnosed are
asymptomatic over symptomatic. According to an article by Pelin Teke Kisa, “Of the 63 patients
with recurrence, 23 were symptomatic and 40 were asymptomatic” (Emir & Kisa). About two
times the number of patients did not show symptoms or any signs of the cancer coming back.
The urgency of screenings becomes transparent in increasing the survival rate of patients.
However, many patients in the U.S can not afford the cost of multiple screenings per
month. According to an article by Crissy Flake, “The economic burden of healthcare results in
about 50% of people reporting they or a family member has delayed care” (Flake & Robert).
That is half of people who reported saying that they or someone they know has not went to a
Coey 4
screening or check-up. Once they have enough money to take the trip it might be too late. Even
if it is not too late, the further the cancer progresses the more the patient must pay resulting in
even more doubt and poor decisions. The actions people are forced to take because they can not
afford healthcare results in more deaths than there should be. Even with insurance the out of
pocket (OOP) costs can be enough to forgo treatment. These costs include prescriptions and
lifestyle changes. According to an article by Toral Parikh, “Even with health insurance, many
patients experience high out of pocket costs and experience practical financial consequences
from medication expenditures” (Parikh et al.). Health insurance may not cover everything
especially if you have a chronic disease such as cancer. This can make patients skip out on
When patients delay treatment or do not fill a prescription, they are increasing the
chance for death at worst and at best causing adverse medical outcomes. The high cost of
healthcare may cause patients to not fill a prescription and without oral medication other
treatment may not be enough. According to an article by Toral Parikh, “and overall health care
was twice as high as the percent of responds without CRPD who gave poor ratings” (Parikh et
al.). CRPD is cost-related prescription delay and patients who reported this were twice as likely
to rate their healthcare poorly. Patients rating their healthcare poorly would make them likely to
Some people might argue that paying for healthcare creates shorter waiting lists for
transplants and that it is better for the economy. It is true that taxes would rise however the safety
of every human being is much more important than money morally. According to a viewpoint
essay by D.W. MacKenzie, “Economist Larry Kotlikoff estimates that average rates of taxation
would have to rise 56 percent to cover projected increases in federal expenditures” (MacKenzie).
Coey 5
Taxes would rise due to free healthcare. This is not necessarily a bad thing considering human
life is what is on the other end. The impact of high healthcare costs negatively affects patients so
much that they would rather delay treatment and risk dying. Considering the following any
logical person would choose a human life over keeping people with money from paying taxes.
Paying for healthcare does not equal shorter waiting lists either. There are some people who pay
to get higher on the waiting list. Waiting lists should be fair and go in order which is made much
more likely to happen when everyone gets the same coverage for healthcare.
Cancer patients have a lower survival rate if they must pay high prices for healthcare. If
healthcare was free people would not have to worry about high prices and everyone would get
the healthcare they deserve. No more losing someone dear and feeling like they were robbed of
the care they deserve. With the implementation of Universal healthcare anyone can get the care
they need.
Coey 6
Works Cited
Bai, Lin, et al. “Differences of Healthcare Utilization and Cost between Cancer Inpatients with
Doble, Brett, et al. “End-of-Life Cost Trajectories and the Trade-off between Treatment Costs
and Life-Extension: Findings from the Cost and Medical Care of Patients with Advanced
Serious Illness (Compass) Cohort Study.” Palliative Medicine, vol. 35, no. 5, 2021, pp.
893–903., https://doi.org/10.1177/0269216321999576.
Flake, Crissy, and Robert Clegg. “Impact of Cost in Delay/Deferral of Care: A Systematic
Literature Review.” Journal of Applied Business and Economics, vol. 22, no. 6, 2020,
https://doi.org/10.33423/jabe.v22i6.3077.
“Health and Economic Costs of Chronic Diseases.” Centers for Disease Control and Prevention,
www.cdc.gov/chronicdisease/about/costs/index.htm.
“Why Does Healthcare Cost so Much?” Blue Cross Blue Shield, www.bcbs.com/issues-
indepth/why-does-healthcare-cost-so-much.
Emir, Suna. “Role of Surveillance Screening in Detecting Tumor Recurrences after Treatment of
Works Cited
MacKenzie, D.W. "Public Health Insurance Programs Are Immoral and Unaffordable." Medical
Parikh, Toral J., et al. “Cost-Related Delay in Filling Prescriptions and Health Care Ratings
among Medicare Advantage Recipients.” Medicine, vol. 98, no. 31, 2019,
doi:10.1097/md.0000000000016469.